Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 16/20 | 0.57 |
| ▸ | GSTM2 | P28161 | 15/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MYC | P01106 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3501565 | 0.82 | GSTP1 (0.52) | GSTP1GSTM2MEN1KMT2AMYC | |
| SCHEMBL7714790 | 0.80 | GSTP1 (0.54) | GSTP1GSTM2MEN1KMT2AMYC | |
| SCHEMBL20353270 | 0.80 | GSTM2 (0.50) | GSTP1GSTM2MEN1KMT2AMYC | |
| SCHEMBL3501548 | 0.79 | MEN1 (0.60) | GSTP1GSTM2MEN1KMT2AMYC | |
| SCHEMBL31320442 | 0.77 | GSTM2 (0.76) | GSTM2MEN1KMT2AMYC | |
| SCHEMBL592618 | 0.77 | GSTM2 (0.76) | GSTM2MEN1KMT2AMYC | |
| SCHEMBL285019 | 0.77 | GSTM2 (0.76) | GSTM2MEN1KMT2AMYC | |
| SCHEMBL27142039 | 0.77 | GSTP1 (0.77) | GSTP1GSTM2 | |
| SCHEMBL459120 | 0.77 | GSTM2 (0.76) | GSTM2MEN1KMT2AMYC | |
| SCHEMBL15515612 | 0.77 | GSTM2 (0.76) | GSTM2MEN1KMT2AMYC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727648-A1 | CANNABINOID RECEPTOR 2 MODULATORS | F. Hoffmann-La Roche AG (CH) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024256505-A1 | CANNABINOID RECEPTOR 2 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2024-12-19 | — | — | WO | disclosed |